These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35661571)

  • 21. Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis.
    Zhang L; Li Y; Wang W; Wang C
    Front Pharmacol; 2022; 13():978876. PubMed ID: 36588743
    [No Abstract]   [Full Text] [Related]  

  • 22. Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis.
    Fang T; Valdes E; Frontera JA
    Neurocrit Care; 2022 Feb; 36(1):248-258. PubMed ID: 34286461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe cutaneous adverse reaction to drug excipient following brand-to-generic switch of levetiracetam.
    Lim JA; Jamil A; Ramli NA; Johar FM; Nor M
    Am J Health Syst Pharm; 2024 Jan; 81(3):e69-e72. PubMed ID: 37864830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of antiseizure medication in post-stroke epilepsy.
    Winter Y; Uphaus T; Sandner K; Klimpe S; Stuckrad-Barre SV; Groppa S
    Seizure; 2022 Aug; 100():109-114. PubMed ID: 35834881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Wlaz A; Karwan S; Florek-Luszczki M; Czuczwar SJ
    Eur J Pharmacol; 2013 Nov; 720(1-3):247-54. PubMed ID: 24161913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness of add-on therapy with newer-generation antiepileptic drugs in Bulgarian patients with refractory epilepsy.
    Viteva E; Zahariev Z
    Epilepsy Behav; 2018 Oct; 87():137-145. PubMed ID: 30097339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
    Patsalos PN; Sander JW
    Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A survey of antiepileptic drug responses identifies drugs with potential efficacy for seizure control in Wolf-Hirschhorn syndrome.
    Ho KS; Markham LM; Twede H; Lortz A; Olson LM; Sheng X; Weng C; Wassman ER; Newcomb T; Wassman ER; Carey JC; Battaglia A
    Epilepsy Behav; 2018 Apr; 81():55-61. PubMed ID: 29477837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
    Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
    Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced liver injury associated with the use of newer antiseizure medications in the elderly: an analysis of data from VigiBase.
    Petrović S; Kovačević M; Vezmar Kovačević S; Miljkovic B
    Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):175-183. PubMed ID: 37071502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential antiseizure medication sensitivity of the Affective Reactivity Index: A randomized controlled trial in new-onset pediatric focal epilepsy.
    Loring DW; Meador KJ; Shinnar S; Gaillard WD; Wheless JW; Kessler SK; Conry JA; Berl MM; Burns TG; Glauser TA; Kinkead B; Cnaan A
    Epilepsy Behav; 2020 Jan; 102():106687. PubMed ID: 31816478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eye disorders associated with newer antiepileptic drugs: A real-world disproportionality analysis of FDA adverse event reporting system.
    Hu W; Chen L; Li H; Liu J
    Seizure; 2022 Mar; 96():66-73. PubMed ID: 35124339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Movement disorders associated with antiseizure medications: A real-world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System.
    Zhou J; Wei Z; Chen S; Xie H; Huang W; Liu M; Wu X
    Br J Clin Pharmacol; 2023 Nov; 89(11):3389-3400. PubMed ID: 37353394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015.
    Du Y; Lin J; Shen J; Ding S; Ye M; Wang L; Wang Y; Wang X; Xia N; Zheng R; Chen H; Xu H
    BMC Pharmacol Toxicol; 2019 Jan; 20(1):7. PubMed ID: 30642405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of epilepsy in adults: expert opinion, 2005.
    Karceski S; Morrell MJ; Carpenter D
    Epilepsy Behav; 2005 Sep; 7 Suppl 1():S1-64; quiz S65-7. PubMed ID: 16102515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiepileptic Drug Treatment in Community-Dwelling Older Patients with Epilepsy: A Retrospective Observational Study of Old- Versus New-Generation Antiepileptic Drugs.
    Theitler J; Brik A; Shaniv D; Berkovitch M; Gandelman-Marton R
    Drugs Aging; 2017 Jun; 34(6):479-487. PubMed ID: 28478592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response.
    Ilhan ZE; Brochard V; Lapaque N; Auvin S; Lepage P
    Neurobiol Dis; 2022 Jun; 167():105664. PubMed ID: 35183703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologic excipients: Importance of clinical awareness of inactive ingredients.
    Ionova Y; Wilson L
    PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures.
    Privitera M; Richy FF; Schabert VF
    Epilepsy Behav; 2022 Jan; 126():108429. PubMed ID: 34864380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.